Month: January 2022

27 January 2022; Golar LNG (“Golar”) is pleased to provide a further update on the formation of Cool Company Ltd. (“CoolCo”). Reference is made to announcements on 15 December 2021 and 20 January 2022, regarding Golar’s announced execution of a Terms Agreement to separate its 8 TFDE LNG carriers into CoolCo. Based on investor feedback following the press releases made on 15 December 2021 and 20 January 2022, CoolCo has decided to launch a book building process of a private placement of $250 million (“The Private Placement”). The anticipated proceeds from the Private Placement will, together with a contemplated debt refinancing, be used to finance the acquisition of the 8 TFDE vessels from Golar, secure attractive financing and provide CoolCo with working capital to position the company for further growth. Eastern Pacific Shipping (“EPS”)...

Highly experienced diagnostics business development executive appointed to lead growth initiatives across international markets and drive international sales of ColoAlert at-home screening test for Colorectal Cancer BERKELEY, Calif. and MAINZ, Germany, Jan. 27, 2022 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today the appointment of Steve Quinn as Vice President of Business Development. “We’re very excited to welcome Steve to the team. He comes to us with strong commercial experience in the field of both molecular genetics and diagnostics,” commented Guido Baechler, Chief Executive Officer of Mainz Biomed. “The impressive global network he has built during his notable business development career...

The Companies Plan to Jointly Submit a Psilocybin Clinical Trial Application to Health Canada VANCOUVER, British Columbia, Jan. 27, 2022 (GLOBE NEWSWIRE) — KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), an evidence-based healthcare company focused on innovative clinical solutions, artificial intelligence-powered digital therapeutics and contract research, is pleased to announce that its wholly owned subsidiary, KGK Science Inc., (“KGK”), has formed a tactical partnership with Nova Mentis Life Science Corp. (“Nova”) (FSE: HN3Q) (OTCQB: NMLSF) to help develop Nova’s psychedelic psilocybin drug portfolio in Canada. Nova is a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders....

NEW YORK, Jan. 27, 2022 (GLOBE NEWSWIRE) — Pipedrive, the global sales-first CRM and intelligent revenue management platform for small businesses, today announced the opening of a newly built Rackspace OpenStack private cloud environment in the UK, provided by Rackspace Technology® (NASDAQ: RXT), a leading end-to-end, multicloud technology solutions company. Now live, the private cloud environment brings Pipedrive closer to its European customers outside of the EU, including in the UK. The presence ensures Pipedrive is able to minimise response times and meet these territories’ security, compliance and data sovereignty requirements. In addition, Pipedrive will be enhancing its managed Amazon Web Services (AWS) environment to launch additional application regions via AWS, further expanding its reach for customers. Pipedrive, the...

LONDON, Jan. 27, 2022 (GLOBE NEWSWIRE) — Global Blood Therapeutics (GBT) today announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has awarded a positive scientific opinion under the Early Access to Medicines Scheme (EAMS) for voxelotor, an oral once-daily tablet under review by the MHRA for the treatment of haemolytic anaemia due to sickle cell disease (SCD) in adults and paediatric patients 12 years of age and older as monotherapy or in combination with hydroxycarbamide. This positive opinion means that those patients living with SCD and meeting the eligibility criteria can gain early, pre-license access to voxelotor, while the MHRA completes its review of the Marketing Authorisation Application (MAA). The aim of EAMS is to grant early access to medicines that have received Promising Innovative...

UPM-Kymmene Corporation        Financial Statements Release 2021        27 January 2022 at 10:00 EET UPM financial statements release 2021:Earnings back to strong pre-pandemic levels, refined completion plan for Uruguay project ready Q4 2021 highlightsSales increased by 22% to EUR 2,673 million (2,188 million in Q4 2020) Comparable EBIT increased by 83% to EUR 461 million, 17.2% of sales (252 million, 11.5%) Operating cash flow was EUR 406 million (347 million) Net debt increased to EUR 647 million (56 million) and net debt to EBITDA ratio was 0.35 (0.04) The unprecedented energy market situation enabled UPM Energy to reach record earnings but added to the paper businesses’ costs The fair value of UPM’s sustainably managed forests increased due to higher wood volume, growth, and price estimates Refined completion plan for...

Press Release Nokia and Nordic Semiconductor to simplify IoT Standard Essential Patent licensingNordic to give customers the opportunity to acquire licenses to Nokia’s cellular IoT technology when they purchase IoT hardware Innovative new arrangement will facilitate amicable and efficient licensing Licenses will be available to Nordic’s customers at the end device level27 January 2022 Espoo, Finland and Oslo, Norway – Nokia and Nordic Semiconductor announced today a pioneering new approach to licensing the use of cellular IoT Standard Essential Patents. Companies purchasing IoT hardware from Nordic will now be given the opportunity to acquire licenses to Nokia’s industry leading portfolio of cellular patents. This new agreement, which is the first of its kind, will simplify and speed up the Standard Essential Patent (SEP) licensing...

Reference is made to press release published on 25 January 2022 notifying that the Extraordinary General Meeting had approved a reverse share split 1,000:1. Please be informed that the ex-date for the reverse share split is today, 27 January 2022. Prosafe is a leading owner and operator of semi-submersible accommodation vessels. The company is listed on the Oslo Stock Exchange with ticker code PRS. For more information, please refer to www.prosafe.com Stavanger, 27 January 2022Prosafe SE For further information, please contact: Jesper K. Andresen, CEOPhone: +47 51 65 24 30 / +47 907 65 155 Stig Harry Christiansen, Deputy CEO and CFOPhone: +47 51 64 25 17 / +47 478 07 813 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act